In this episode, Anna breaks down a recent study exploring brain neurochemicals in Long COVID and ME/CFS — with a particular focus on glutamate and its potential role in symptoms, particularly physical capacity.
Rather than simply summarising the research, Anna walks you through what these findings may actually mean in practice. We’ll explore how glutamate fits into the wider picture of nervous system regulation, inflammation, and energy metabolism — and why these conditions can’t be understood through a single lens.
Anna talks about where targeted approaches like diet, supplements, or medication may have a role, and why addressing underlying drivers is often key to more meaningful, sustainable progress.
This episode is designed to help you make sense of the science — without oversimplifying it — and to offer a more integrated way of understanding your symptoms.
Podden och tillhörande omslagsbild på den här sidan tillhör
Anna Marsh. Innehållet i podden är skapat av Anna Marsh och inte av,
eller tillsammans med, Poddtoppen.
